Table 3 Comparison of total, baseline and new or aggravated clinical symptoms between L-CI and N-CI

 Bradykinesia

66

48

NA

66/11

48/10

NA

0.571^c

 Rest tremor

57

41

0.886^c

58/7

43/9

0.777^c

0.123^c

 Rigidity

35

31

0.217^c

37/8

34/10

0.108^c

0.208^c

30

18

0.396^c

55/28

26/10

0.001^c

0.016^c

 RCP

9

3

0.337^e

22/13

7/4

0.023^c

0.157^c

 Cognitive impairment

0

0

NA

66/0

0/0

NA

NA

 Somnipathy

10

7

0.933^c

23/13

16/9

0.866^c

0.899^c

 Anxiety

28

13

0.092^c

33/7

22/9

0.660^c

0.123^c

 Depression

27

9

0.012^c

35/10

17/9

0.062^c

0.611^c

 Apathy

4

2

0.982^e

5/1

2/0

0.724^e

NA

 Constipation

45

26

0.127^c

54/15

35/9

0.257^c

0.607^c

 Hyperhidrosis

0

1

NA

1/1

2/1

0.779^e

NA*

 Postural hypotension

13

6

0.309^c

25/13

17/11

0.788^c

0.677^c

 Dysuria

34

23

0.704^c

44/11

34/11

0.637^c

0.404^c

 Salivation

11

4

0.308^e

16/5

8/4

0.327^c

NA*

 Sexual dysfunction

4

9

0.071^e

6/2

10/1

0.075^c

NA

 Olfactory dysfunction

16

20

0.048^c

27/11

26/6

0.161^c

0.537^c

 Pain

11

8

NA*

16/6

11/5

0.896^c

0.813^c

 Spasm

0

1

NA

0/0

1/0

NA

NA

 Numbness

3

2

NA*

4/2

2/0

0.982^e

NA

 RLS

3

1

0.849^e

3/0

1/0

0.873^e

NA